Lymphocyte activation in the lungs of SP-D null mice.
Surfactant protein D (SP-D) appears to play an important role in regulating local pulmonary inflammatory responses to pathogens. There is also in vitro evidence that SP-D may suppress local T cell responses. However, the role of SP-D in regulating T cell responses directly in the lung has not been previously evaluated in vivo. SP-D(-)(/-) mice demonstrate peribronchial and perivascular accumulations of lymphocytes. Therefore, we investigated the functional status and abundance of intrapulmonary lymphocytes in SP-D(-)(/-) mice. By morphometric analysis, SP-D(-)(/-) mice demonstrated increased numbers of airway- and vessel-associated lymphocytes without increases in interstitial lymphocytes. There was increased proliferative activity of lymphocytes isolated by enzymatic disassociation of minced lung. Flow cytometry was used to determine the number and functional activation status of intrapulmonary CD4(+) and CD8(+) T cells, as well as B cells and NK cells. Cytokine expression patterns in lung tissues were evaluated using RNase protection assays, reverse transcriptase/polymerase chain reaction, and enzyme-linked immunosorbent assay. There was marked T cell activation in the lungs of SP-D(-)(/-) mice, as reflected by an increased percentage of both CD4(+) and CD8(+) T cells expressing CD69 and CD25. BAL CD4 lymphocytes were increased and the fraction expressing CD69 was also increased. Although there were increases in BAL CD8 lymphocytes, apparent increases in CD69-positive CD8 lymphocytes did not reach statistical significance. In contrast, splenic T cells were not activated in SPD(-)(/-) mice. Of the proinflammatory cytokines evaluated, only interleukin (IL)-12 and IL-6 expression were consistently upregulated in the lungs of SPD(-)(/-) mice. Increased IL-2 expression was apparent but did not reach statistical significance. We conclude that the lack of local pulmonary production of SP-D leads to a state of persistent T cell activation, possibly in response to exogenous antigens. This study therefore provides further evidence of the important local immunoregulatory role of SP-D in vivo.
Fisher
James H
JH
Division of Pulmonary Sciences and Critical Care Medicine, Denver Health Medical Center, Colorado 80204-4507, USA. James.Fisher@dhha.org
Larson
Jaque
J
Cool
Carlyne
C
Dow
Steve W
SW
D000818:Animals; D015703:Antigens, CD / Q000096:biosynthesis / Q000276:immunology; D000945:Antigens, Differentiation, T-Lymphocyte / Q000096:biosynthesis / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism*; D002455:Cell Division; D006023:Glycoproteins / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D007376:Interleukin-2 / Q000096:biosynthesis / Q000276:immunology; D015850:Interleukin-6 / Q000096:biosynthesis / Q000276:immunology; D037181:Lectins, C-Type; D008168:Lung / Q000276:immunology* / Q000502:physiology; D008213:Lymphocyte Activation / Q000276:immunology* / Q000502:physiology; D051379:Mice; D008822:Mice, Transgenic; D037663:Pulmonary Surfactant-Associated Protein D; D011663:Pulmonary Surfactants / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D015375:Receptors, Interleukin-2 / Q000096:biosynthesis / Q000276:immunology; D000099192:CD69 Antigens
D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D006023:Glycoproteins; D007376:Interleukin-2; D015850:Interleukin-6; D037181:Lectins, C-Type; D037663:Pulmonary Surfactant-Associated Protein D; D011663:Pulmonary Surfactants; D015375:Receptors, Interleukin-2; D000099192:CD69 Antigens